ClinicalTrials.Veeva

Menu

Simvatstatin Used to Treat Pulmonary Hypertension

C

Capital Medical University

Status and phase

Unknown
Phase 1

Conditions

Hypertension, Pulmonary

Treatments

Drug: simvastatin

Study type

Interventional

Funder types

Other

Identifiers

NCT00538044
Anzhen1
Gan1

Details and patient eligibility

About

we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

Full description

advanced pulmonary hypertension is refractory to the medication in use nowaday, especially pulmonary hypertension secondary to congenital heart disease or chronic pulmonary embolism.It is revealed that statins may intefere the pathogenisis of the pulmonary hypertension in many key poing, such as improving apotosis or inhiting the proliferation of pulmonary vascular smooth muscle cell. so we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

Sex

All

Ages

12 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pasp>50mmHg

Exclusion criteria

  • pasp<50mmhg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

1simvastatin group
Experimental group
Description:
before the operation, the patient start the simvastatin medication on the dosage of 40mg per day
Treatment:
Drug: simvastatin
2contral group
No Intervention group
Description:
just do routin operation with no use of simvastatin, other medication is exact the same as the simvastatin group

Trial contacts and locations

1

Loading...

Central trial contact

Huili Gan, MD,Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems